Avtar Dhillon of Emerald Health Talks Pure Sunfarms, Edibles and Nutraceuticals

written by Matthew Carr
Thursday, January 31, 2019

This is individual research and does not constitute investment advice.

The Super Bowl is this Sunday, so it’s quite fitting that in today’s episode of CannaBiz Now! I talk to the CEO of a company that has 18 football fields’ worth of growing space.

Emerald Health Therapeutics’ (OTC: EMHTF) joint venture Pure Sunfarms is a monstrous 1.1 million square feet. And in this case, bigger is better.

Emerald Health is one of the most diverse Canadian producers. It has its hands in a wide variety of businesses and is on a path to becoming a household name.

In our interview, CEO Dr. Avtar Dhillon shared Emerald Health’s mandate of global expansion, as well as the number of acquisitions the company has recently made to boost its international and domestic presence.

We also discussed the upcoming legal edibles market in Canada and Emerald Health’s plan there. Additionally, its high-margin nutraceutical products are already making their way onto the shelves of major retailers.

The nutraceuticals market is poised to be worth more than $578 billion by 2025. Add that to the more than $200 billion that cannabis is expected to be worth over the next decade… and Emerald Health is sitting on a nearly $1 trillion opportunity.

Marijuana stocks kicked off the year with a bang, but you’ll learn from Dr. Dhillon that there’s plenty more for investors to be excited about in the months ahead.

Good investing,

Matthew